Bayer HealthCare's Consumer Care Division on Tuesday introduced Bayer Migraine Formula, an over-the-counter medication designed to relieve migraine pain and accompanying symptoms like nausea, phonophobia (sound sensitivity) and photophobia (light sensitivity) through a formulation of aspirin, acetaminophen and caffeine.
Johnson & Johnson Consumer earlier this summer put the freeze on pain with the launch of its Bengay Zero Degrees line extension, an external analgesic rub that makes its home alongside the frozen peas in the freezer.
Five pharmacy organizations on Thursday wrote Congress in opposition of an amendment to the Food and Drug Administration Safety Innovation Act due to its potential to delay patients' timely relief from chronic pain while increasing drug costs.
To encourage consumers to rethink aspirin for pain relief — according to a recent Bayer survey, only 8% of respondents reported taking aspirin more often that other OTC pain relievers — Bayer on Tuesday issued the Fast Relief Challenge and is giving away 100,000 bottles of Bayer Advanced Aspirin so consumers can put the pain reliever to the test.
A Food and Drug Administration panel will meet Monday to discuss a class of drugs designed to treat chronic painful conditions that currently are under development and the safety issues possibly related to the drugs.
The National Advertising Review Board on Tuesday recommended that Novartis Consumer Health discontinue advertising claims that the company’s Excedrin Extra Strength product starts relieving headache pain faster than Advil.